Hyams D, Byun J, Martin B, Bailey C, Stumpf T, Petkov V. Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease. J of Skin [Internet]. 2023Jul.17 [cited 2024Oct.26];7(4):s223. Available from: https://skin.dermsquared.com/skin/article/view/2198